AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 143 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $42,214 | -43.1% | 6,616,423 | -1.0% | 0.01% | -40.0% |
Q2 2023 | $74,129 | -29.6% | 6,684,241 | -2.6% | 0.01% | -37.5% |
Q1 2023 | $105,369 | -29.2% | 6,864,385 | +2.3% | 0.02% | -33.3% |
Q4 2022 | $148,835 | -99.8% | 6,707,287 | +29.8% | 0.02% | +71.4% |
Q3 2022 | $84,412,000 | -26.3% | 5,169,023 | -34.4% | 0.01% | 0.0% |
Q2 2022 | $114,542,000 | -22.3% | 7,883,125 | -1.3% | 0.01% | -6.7% |
Q1 2022 | $147,493,000 | -19.7% | 7,985,535 | +3.3% | 0.02% | -11.8% |
Q4 2021 | $183,786,000 | +5.2% | 7,731,846 | +9.0% | 0.02% | +6.2% |
Q3 2021 | $174,643,000 | +178.6% | 7,090,650 | +179.5% | 0.02% | +166.7% |
Q2 2021 | $62,691,000 | +63.5% | 2,537,071 | +44.3% | 0.01% | +50.0% |
Q1 2021 | $38,336,000 | +59.0% | 1,757,735 | +86.0% | 0.00% | +100.0% |
Q4 2020 | $24,112,000 | -10.6% | 944,838 | -1.3% | 0.00% | -33.3% |
Q3 2020 | $26,958,000 | +0.4% | 957,651 | +0.8% | 0.00% | 0.0% |
Q2 2020 | $26,858,000 | – | 950,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 849,651 | $13,042,143 | 13.77% |
COWEN AND COMPANY, LLC | 4,592,966 | $70,502,028 | 8.28% |
Cormorant Asset Management, LP | 2,612,115 | $40,096 | 2.64% |
5AM Venture Management, LLC | 665,555 | $10,216,269 | 2.61% |
RA Capital Management | 6,416,998 | $98,500,919 | 2.23% |
RTW INVESTMENTS, LP | 6,387,178 | $98,043,182 | 2.04% |
COMMODORE CAPITAL LP | 590,705 | $9,067,322 | 1.38% |
Casdin Capital, LLC | 850,000 | $13,047,500 | 1.08% |
Boxer Capital, LLC | 1,121,327 | $17,212 | 0.85% |
Octagon Capital Advisors LP | 382,000 | $5,863,700 | 0.84% |